Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · IEX Real-Time Price · USD
99.76
+0.80 (0.81%)
At close: Jul 19, 2024, 4:00 PM
99.77
+0.01 (0.01%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Ligand Pharmaceuticals Revenue
Ligand Pharmaceuticals had revenue of $118.31M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $30.98M. In the year 2023, Ligand Pharmaceuticals had annual revenue of $131.31M.
Revenue (ttm)
$118.31M
Revenue Growth
-41.92%
P/S Ratio
15.15
Revenue / Employee
$2,039,879
Employees
58
Market Cap
1.79B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 131.31M | -64.93M | -33.09% |
Dec 31, 2022 | 196.25M | -45.30M | -18.75% |
Dec 31, 2021 | 241.54M | 77.98M | 47.68% |
Dec 31, 2020 | 163.56M | 43.28M | 35.98% |
Dec 31, 2019 | 120.28M | -131.17M | -52.17% |
Dec 31, 2018 | 251.45M | 110.35M | 78.21% |
Dec 31, 2017 | 141.10M | 32.13M | 29.48% |
Dec 31, 2016 | 108.97M | 37.06M | 51.53% |
Dec 31, 2015 | 71.91M | 7.38M | 11.43% |
Dec 31, 2014 | 64.54M | 15.57M | 31.78% |
Dec 31, 2013 | 48.97M | 17.59M | 56.02% |
Dec 31, 2012 | 31.39M | 1.35M | 4.50% |
Dec 31, 2011 | 30.04M | 6.50M | 27.61% |
Dec 31, 2010 | 23.54M | -15.40M | -39.55% |
Dec 31, 2009 | 38.94M | 11.63M | 42.56% |
Dec 31, 2008 | 27.32M | 14.42M | 111.84% |
Dec 31, 2007 | 12.89M | 8.92M | 224.21% |
Dec 31, 2006 | 3.98M | -6.24M | -61.07% |
Dec 31, 2005 | 10.22M | -101.90M | -90.89% |
Dec 31, 2004 | 112.11M | 30.99M | 38.21% |
Dec 31, 2003 | 81.12M | 9.35M | 13.03% |
Dec 31, 2002 | 71.77M | -4.57M | -5.99% |
Dec 31, 2001 | 76.34M | 28.23M | 58.68% |
Dec 31, 2000 | 48.11M | 7.22M | 17.64% |
Dec 31, 1999 | 40.90M | 23.22M | 131.40% |
Dec 31, 1998 | 17.67M | -34.03M | -65.82% |
Dec 31, 1997 | 51.70M | 14.86M | 40.33% |
Dec 31, 1996 | 36.84M | 12.33M | 50.28% |
Dec 31, 1995 | 24.52M | 11.21M | 84.21% |
Dec 31, 1994 | 13.31M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Harmony Biosciences Holdings | 617.51M |
Veracyte | 375.47M |
Zai Lab | 291.07M |
RxSight | 101.10M |
Keros Therapeutics | 234.00K |
LGND News
- 14 days ago - Ligand to Acquire APEIRON Biologics AG for $100 Million - Business Wire
- 25 days ago - Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years - Business Wire
- 4 weeks ago - Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults - Business Wire
- 2 months ago - Ligand to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Ligand Reports First Quarter 2024 Financial Results - Business Wire
- 2 months ago - Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement - Business Wire
- 3 months ago - Ligand to Report First Quarter 2024 Financial Results on May 7, 2024 - Business Wire
- 3 months ago - Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference - Business Wire